文献速递免疫规划

基于结构设计的模块化衣壳粒包含HA1用于低成本家禽流感疫苗接种

Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination.
PubMed 文献 · Vaccine · 2016-11-25

研究开发了基于改良鼠多瘤病毒VP1衣壳粒展示结构设计的流感血凝素HA1抗原的模块化衣壳粒,作为低成本家禽流感疫苗。该模块化衣壳粒(CaptHA1-3C)可在大肠杆菌中以稳定形式生产且无需蛋白质重折叠。在鸡中施用佐剂化CaptHA1-3C可诱导强抗体反应(终点滴度几乎105),与昆虫细胞来源HA1蛋白组相似,且攻毒后获得完全保护。

要点

  • 模块化衣壳粒CaptHA1-3C可在大肠杆菌中稳定生产,无需蛋白质重折叠。
  • 佐剂化CaptHA1-3C在鸡中诱导强抗体反应,终点滴度几乎105。
  • 接种佐剂化CaptHA1-3C的鸡在HPAI病毒攻毒后获得完全保护。

核心结论

  • 该细菌生产的模块化衣壳粒平台可能转化为快速响应且低成本的家禽疫苗接种制造技术。

研究设计与样本

  • 研究开发了模块化衣壳粒作为低成本家禽流感疫苗,使用改良鼠多瘤病毒(MuPyV)VP1衣壳粒展示结构设计的流感血凝素(HA1)抗原。
  • 生成了六种展示三种截短HA1版本的模块化衣壳粒构建体和两种展示未修饰HA1的模块化衣壳粒构建体。

主要发现

  • 模块化衣壳粒在大肠杆菌中以稳定形式成功生产,无需蛋白质重折叠。
  • 基于ELISA,佐剂化模块化衣壳粒(CaptHA1-3C)在鸡中诱导强抗体反应(终点滴度几乎105),与施用昆虫细胞来源HA1蛋白组获得的滴度相似。
  • 接受佐剂化CaptHA1-3C随后用HPAI病毒攻毒的鸡获得完全保护。

关键数值与推荐

  • 佐剂化CaptHA1-3C在鸡中诱导的抗体终点滴度几乎105。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Highly pathogenic avian influenza (HPAI) viruses cause a severe and lethal infection in domestic birds. The increasing number of HPAI outbreaks has demonstrated the lack of capabilities to control the rapid spread of avian influenza. Poultry vaccination has been shown to not only reduce the virus spread in animals but also reduce the virus transmission to humans, preventing potential pandemic development. However, existing vaccine technologies cannot respond to a new virus outbreak rapidly and at a cost and scale that is commercially viable for poultry vaccination. Here, we developed modular capsomere, subunits of virus-like particle, as a low-cost poultry influenza vaccine. Modified murine polyomavirus (MuPyV) VP1 capsomere was used to present structural-based influenza Hemagglutinin (HA1) antigen. Six constructs of modular capsomeres presenting three truncated versions of HA1 and two constructs of modular capsomeres presenting non-modified HA1 have been generated. These modular capsomeres were successfully produced in stable forms using Escherichia coli, without the need for protein refolding. Based on ELISA, this adjuvanted modular capsomere (CaptHA1-3C) induced strong antibody response (almost 105endpoint titre) when administered into chickens, similar to titres obtained in the group administered with insect cell-based HA1 proteins. Chickens that received adjuvanted CaptHA1-3C followed by challenge with HPAI virus were fully protected. The results presented here indicate that this platform for bacterially-produced modular capsomere could potentially translate into a rapid-response and low-cost vaccine manufacturing technology suitable for poultry vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Waneesorn J, Wibowo N, Bingham J, et al. Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination. Vaccine. 2016. PMID: 27894719. doi:10.1016/j.vaccine.2016.11.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。